Patten & Patten Inc Abb Vie Inc. Transaction History

Patten & Patten Inc

$1.43 Billion
Q3 2024

A detailed history of Patten & Patten Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Patten & Patten Inc holds 185,936 shares of ABBV stock, worth $32.9 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares

185,936

Previous 188,212 1.21%

Holding current value

$32.9 Million

Previous $32.3 Million 13.74%

% of portfolio

2.57%

Previous 2.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$163.84 - $199.33 $372,899 - $453,675	-2,276 Reduced 1.21%	185,936 $36.7 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $599,501 - $700,083	-3,873 Reduced 2.02%	188,212 $32.3 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $30.7 Million - $35 Million	192,085 New	192,085 $35 Million
Q4 2023 Jan 23, 2024	SELL	$137.6 - $154.97 $80,496 - $90,657	-585 Reduced 0.3%	194,533 $30.1 Million
Q3 2023 Oct 27, 2023	BUY	$133.59 - $154.65 $90,974 - $105,316	681 Added 0.35%	195,118 $29.1 Million
Q2 2023 Jul 14, 2023	BUY	$132.51 - $164.9 $1.06 Million - $1.32 Million	7,978 Added 4.28%	194,437 $26.2 Million
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $329,276 - $379,211	-2,277 Reduced 1.21%	186,459 $29.7 Million
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $677,719 - $812,763	-4,900 Reduced 2.53%	188,736 $30.5 Million
Q3 2022 Oct 19, 2022	SELL	$134.21 - $153.93 $290,027 - $332,642	-2,161 Reduced 1.1%	193,636 $26 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $782,232 - $994,472	-5,684 Reduced 2.82%	195,797 $30 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $720,478 - $893,911	-5,459 Reduced 2.64%	201,481 $32.7 Million
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $234,089 - $296,191	-2,179 Reduced 1.04%	206,940 $28 Million
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $37,984 - $43,118	357 Added 0.17%	209,119 $22.6 Million
Q2 2021 Jul 13, 2021	BUY	$105.21 - $117.21 $581,495 - $647,819	5,527 Added 2.72%	208,762 $23.5 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $299,125 - $329,300	2,924 Added 1.46%	203,235 $22 Million
Q4 2020 Jan 19, 2021	BUY	$80.49 - $108.67 $447,524 - $604,205	5,560 Added 2.85%	200,311 $21.5 Million
Q3 2020 Oct 08, 2020	BUY	$85.91 - $100.83 $772,674 - $906,865	8,994 Added 4.84%	194,751 $17.1 Million
Q2 2020 Jul 21, 2020	BUY	$73.37 - $98.18 $105,946 - $141,771	1,444 Added 0.78%	185,757 $18.2 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $85,914 - $130,256	1,332 Added 0.73%	184,313 $14 Million
Q4 2019 Jan 13, 2020	BUY	$72.13 - $90.25 $1.17 Million - $1.46 Million	16,189 Added 9.71%	182,981 $16.2 Million
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $24,247 - $29,152	385 Added 0.23%	166,792 $12.6 Million
Q2 2019 Jul 11, 2019	SELL	$65.7 - $83.98 $600,038 - $766,989	-9,133 Reduced 5.2%	166,407 $12.1 Million
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $131,909 - $155,250	-1,710 Reduced 0.96%	175,540 $14.1 Million
Q4 2018 Jan 17, 2019	SELL	$77.85 - $96.01 $779,434 - $961,252	-10,012 Reduced 5.35%	177,250 $16.3 Million
Q3 2018 Oct 17, 2018	BUY	$88.91 - $98.84 $246,280 - $273,786	2,770 Added 1.5%	187,262 $17.7 Million
Q2 2018 Jul 18, 2018	BUY	$89.78 - $106.23 $133,233 - $157,645	1,484 Added 0.81%	184,492 $17.1 Million
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $91,457 - $122,470	-994 Reduced 0.54%	183,008 $17.3 Million
Q4 2017 Jan 22, 2018	SELL	$89.56 - $98.21 $374,181 - $410,321	-4,178 Reduced 2.22%	184,002 $17.8 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $13.1 Million - $16.8 Million	188,180	188,180 $16.7 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.

Account

Patten & Patten Inc Abb Vie Inc. Transaction History